Targeting the insulin-like growth factor-1 receptor to overcome imatinib resistance in chronic myeloid leukemia
Abstract Patients with chronic myeloid leukemia (CML) frequently develop resistance to tyrosine kinase inhibitors such as imatinib. In this study, we explored the role of the insulin-like growth factor 1 (IGF-1) signaling pathway in CML and imatinib resistance. An analysis of IGF-1 gene expression u...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Springer
2024-12-01
|
| Серія: | Discover Oncology |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1007/s12672-024-01706-6 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|